Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel in Healthy Subjects Aged 9 to 60 Years in the Philippines
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2018
At a glance
- Drugs CYD TDV (Primary) ; DTaP vaccine (Primary)
- Indications Dengue; Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors sanofi pasteur
- 05 Feb 2018 Planned end date changed from 18 Dec 2018 to 12 Aug 2019.
- 05 Feb 2018 Planned primary completion date changed from 18 Dec 2018 to 12 Aug 2019.
- 24 Nov 2017 Planned End Date changed from 2 Jan 2019 to 18 Dec 2018.